Research

Goldenseal (Hydrastis canadensis)

5 peer-reviewed studies curated from PubMed and Semantic Scholar.

0
Meta-analyses
0
Systematic reviews
4
RCTs
1
Other studies
RCTs (80%)

Studies

Sorted by quality and recency

2025·Clinical and translational science·James T Nguyen, Christopher M Arian, Rakshit S Tanna, et al

The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes.

RCT

This three-arm, open-label, crossover clinical study assessed the pharmacokinetic interaction between goldenseal and metformin in adults with type 2 diabetes. The study found that goldenseal decreased metformin systemic exposure at lower doses, but the overall interaction was not clinically meaningful. The study highlights the need to evaluate clinical biomarkers for drug interaction risks involving natural products.

PubMedRead on PubMed
2007·Clinical pharmacology and therapeutics·B J Gurley, A Swain, M A Hubbard, et al

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.

RCTn = 16

RCT evaluating the effects of goldenseal and kava kava supplementation on human CYP3A activity using midazolam as a probe. Goldenseal significantly inhibited CYP3A activity, while kava kava did not affect midazolam disposition.

PubMedRead on PubMed
2006·Drug metabolism and disposition: the biological fate of chemicals·Bill J Gurley, Ashley Swain, Gary W Barone, et al

Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.

RCTn = 20

RCT with 20 healthy volunteers to assess the effect of goldenseal and kava kava supplementation on digoxin pharmacokinetics. Goldenseal showed a 14% increase in C(max), but no other significant effects on digoxin pharmacokinetics were observed. The study suggests these supplements are not potent modulators of P-gp in vivo.

PubMedRead on PubMed
2005·Clinical pharmacology and therapeutics·Bill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

RCTn = 12

RCT with 12 healthy volunteers assessing the effects of goldenseal, kava kava, black cohosh, and valerian on CYP enzyme activity. Goldenseal significantly inhibited CYP2D6 and CYP3A4/5 activity, kava kava inhibited CYP2E1, and black cohosh weakly inhibited CYP2D6. Valerian showed no significant changes in enzyme activity.

PubMedRead on PubMed
2020·Clinical Pharmacology & Therapeutics·James T. Nguyen, Dan‐dan Tian, Rakshit S. Tanna, et al

Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

In vitron = 16

The study evaluated the effects of goldenseal, standardized to berberine, on transporter activity using in vitro systems and a clinical probe cocktail in 16 healthy volunteers. Goldenseal increased the AUC of midazolam but had no effects on rosuvastatin and furosemide pharmacokinetics, while decreasing metformin AUC, suggesting altered intestinal permeability and transport.

Semantic ScholarRead on Semantic Scholar